Agios Pharmaceuticals: A More Compelling Valuation (NASDAQ:AGIO)

This article was written by Follow Bret Jensen has over 13 years as a market analyst,…

Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside

This article was written by Follow I hold a PhD in Machine Learning focused on Economics…

Arrowhead Pharmaceuticals: A Reluctant Sell Rating Explained (Rating Downgrade) (ARWR)

This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering…

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON)

This article was written by Follow My handle is the Michigan Value Investor, but everyone calls…

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company…

Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call Transcript

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) Q1 2025 Earnings Conference Call May 6, 2024 4:30 PM ET Company…

Phathom Pharmaceuticals, Inc. (PHAT) Q1 2025 Earnings Call Transcript

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2025 Earnings Call May 1, 2025 8:00 AM ET Company Participants…

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth (NASDAQ:IRWD)

This article was written by Follow Biologics is a full-time healthcare investor who developed a passion…

Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

Newer and more expensive medications are more likely to be made in the United States or…

Centessa Pharmaceuticals: Smooth Move To New Programs, But Questions Remain (NASDAQ:CNTA)

This article was written by Follow Avisol Capital Partners is made up of a team of…